Semliki Forest virus-induced demyelination and remyelination - Involvement of B cells and anti-myelin antibodies

Journal of Neuroimmunology

Volumn 137, Issue 1-2, 2003, Pages 19-31

  Mokhtarian, Foroozan ^a,b   Huan, Chong Min ^b   Roman, Christopher ^b   Raine, Cedric S ^c  

^a MAIMONIDES MEDICAL CENTER   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Anti myelin antibodies; Demyelination and remyelination; Semliki Forest

Indexed keywords

ANTIBODY; CD11B ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; MYELIN PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BRAIN INFECTION; BRAIN NERVE CELL; BRAIN STEM; CELL MATURATION; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATION; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNE RESPONSE; MICROGLIA; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; REMYELINIZATION; SEMLIKI FOREST ALPHAVIRUS; T LYMPHOCYTE; VIRUS INFECTION; WHITE MATTER;

EID: 0037377273     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00039-0     Document Type: Article

References (60)

1. Beraud E., Reshef T., Vandenbark A.A., Offner H., Fritz R., Chou C.H., Bernard D., Cohen I.R. Experimental autoimmune encephalomyelitis mediated by T lymphocyte lines: genotype of antigen-presenting cells influences immunodominant epitope of basic protein. J. Immunol. 136:1986;511-517.
2. Bergmann C.C., Marten N.W., Hinton D.R., Parra B., Stohlman S.A. CD8 T cell mediated immunity to neurotropic MHV infection. Adv. Exp. Med. Biol. 494:2001;299-308.
3. Brahic M., Bureau J., McAllister A. Genetic determinants of the demyelinating disease caused by Theiler's virus. Microb. Pathog. 11:1991;77-84.
4. Brosnan C.F., Raine C.S. Mechanisms of immune injury in multiple sclerosis. Brain Pathol. 6:1996;243-257.
5. Casellas R., Nussenzweig A., Wuerffel R., Pelanda R., Reichlin A., Suh H., Qin X., Besmer E., Kenter A., Rajewsky K., Nussenzweig M. Ku 80 is required for immunoglobulin isotype switching. EMBO J. 17:1998;2404-2411.
6. Cristallo A., Gambaro F., Biamonti G., Ferrante P., Battaglia M., Cereda P.M. Human coronavirus polyadenylated RNA sequences in cerebrospinal fluid from multiple sclerosis patients. New Microbiol. 20:1997;105-114.
7. Cross A.H., Trotter J.L., Lyons J. B cells and antibodies in CNS demyelinating disease. J. Immunol. 112:2001;1-14.
8. Fazakerley J.K., Amor S., Webb H.E. Reconstitution of Semliki Forest virus infected mice induces immune mediated pathological changes in the CNS. Clin. Exp. Immunol. 52:1983;115-120.
9. Fazakerley J.K., Parker S.E., Bloom F., Buchmeier M.J. The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system. Virology. 187:1992;178-188.
10. Fazakerley J.K., Amor S., Nash A.A. Russell W.C. Animal Model Systems of MS. Molecular Biology of Multiple Sclerosis. 1997;255-273 C. Wiley, Chichester.
11. Fujinami R.S., Oldstone M.B.A. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science. 230:1985;1043-1045.
12. Gautam A.M., Liblau R., Chelvanayagam G., Steinman L., Boston T. A viral peptide with limited homology to a self peptide can induce clinical signs of experimental autoimmune encephalomyelitis. J. Immunol. 161:1998;60-64.
13. Genain C.P., Abel K., Belmar N., Vilinger F., Rosenberg D.P., Linington C., Raine C.S., Hauser S.L. Late complications of immune deviation therapy in a nonhuman primate. Science. 274:1996;2054-2057.
14. Greer J.M., Sobel R.A., Sette A., Southwood S., Lees M.B., Kuchroo V.K. Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J. Immunol. 156:1996;371-379.
15. Hjelmstrom P., Juedes A.E., Fjell J., Ruddle N.H. B cell deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J. Immunol. 161:1998;4480-4483.
16. Jahnke U., Fischer E.H., Alvord E.C. Jr. Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis. Science. 229:1985;282-284.
17. Johns T.G., Kerlero de Rosbo N., Menon K.K., Abo S., Gonzales M.F., Bernard C.C.A. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J. Immunol. 154:1995;5536-5541.
18. Knopf P.M., Harling-Berg C.J., Cserr H.F., Basu D., Sirulnick E.J., Nolan S.C., Park J.T., Keir G., Thompson E.J., Hickey W.F. Antigen-dependent intrathecal antibody synthesis in the normal rat brain: tissue entry and local retention of antigen-specific B cells. J. Immunol. 161:1998;692-701.
19. Lampert P.W., Simms J.K., Kniazeff A.J. Mechanism of demyelination in JHM virus encephalomyelitis. Electron microscopic studies. Acta Neuropathol., Suppl. 24:1973;76-85.
20. Lane T.E., Buchmeier M.J. Murine coronavirus infection: a paradigm for virus-induced demyelinating disease. Trends Microbiol. 5:1997;9-14.
21. Liebert U.G., Linington C., ter Meulen V. Induction of autoimmune reactions to myelin basic protein in measles virus encephalitis in Lewis rats. J. Neuroimmunol. 17:1988;103-118.
22. Lipton H.L., Jelachich L. Molecular pathogenesis of Theiler's murine encephalomyelitis virus-induced demyelinating disease in mice. Intervirology. 40:1997;143-152.
23. Lyons J.A., San M., Happ M.P., Cross A.H. B cells are critical to induction of experimental allergic encephalitis by protein but not a short encephalitogenic peptide. Eur. J. Immunol. 29:1999;3432-3439.
24. Marten N.W., Stohlman S.A., Bergmann C.C. Role of viral persistence in retaining CD8(+) T cells within the central nervous system. J. Virol. 74:2000;7903-7910.
25. Mendel I., Kerlero de Rosbo N., Ben-Nun A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor Vβ expression of encephalitogeniic T cells. Eur. J. Immunol. 25:1995;1951-1959.
26. Miller D.J., Asakura K., Rodriguez M. Experimental strategies to promote central nervous system remyelination in multiple sclerosis: insight gained from the Theiler's virus model system. J. Neurosci. Res. 41:1995;291-296.
27. Miller S.D., Olson J., Croxford J. Multiple pathways to induction of virus-induced autoimmune demyelination: lessons from Theiler's infection. J. Autoimmun. 16:2001;219-227.
28. Mokhtarian F., Griffin D.E. The role of mast cells in virus-induced inflammation in the murine central nervous system. Cell. Immunol. 86:1984;491-500.
29. Mokhtarian F., Swoveland P. Predisposition to EAE induction in resistant mice by prior infection with Semliki Forest virus. J. Immunol. 138:1987;3264-3268.
30. Mokhtarian F., Wesselingh S.L., Choi S., Maeda A., Griffin D.E., Sobel R.A., Grob D. Production and role of cytokines in the CNS of mice with acute viral encephalomyelitis. J. Neuroimmunol. 66:1996;11-22.
31. Mokhtarian F., Zhang Z., Shi Y., Gonzales E., Sobel R.A. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice. J. Neuroimmunol. 95:1999;43-54.
32. Morris-Downes M.M., Smith P.A., Rundle J.L., Piddlesten S.J., Baker D., Pham-Dinh D., Heijimans N., Amor S. Pathological and regulatory effects of anti-myelin antibodies in experimental encephalomyelitis in mice. J. Neuroimmunol. 125:2002;114-124.
33. Oldstone M.B.A. Molecular mimicry: immunologic cross-reactivity between dissimilar proteins (microbial and self) that share common epitopes can lead to autoimmunity. Cell. 50:1987;819-820.
34. Olson J.K., Calenoff M.A., Dal Canto M.C., Miller S.D. A virus-induced mimicry model of multiple sclerosis. J. Clin. Invest. 108:2001;311-318.
35. Parsons L.M., Webb H.E. Blood brain barrier disturbance and immunoglobulin G levels in the cerebrospinal fluid of the mouse following peripheral infection with the demyelinating strain of Semliki Forest virus. J. Neurol. Sci. 57:1982;307-318.
36. Parsons L.M., Webb H.E. Identification of immunoglobulin-containing cells in the central nervous system of the mouse following infection with the demyelinating strain of Semliki Forest virus. Br. J. Exp. Pathol. 70:1989;255-257.
37. Parsons L.M., Webb H.E. IgG subclass responses in brain and serum in Semliki Forest virus demyelinating encephalitis. Neuropathol. Appl. Neurobiol. 18:1992;351-359.
38. Pathak S., Illavia S.J., Khalili-Shirazi A., Webb H.E. Immunoelectron microscopical labeling of a glycolipid in the envelopes of brain cell-derived budding viruses, Semliki Forest, influenza and measles, using a monoclonal antibody directed chiefly against galactocerebroside resulting from Semliki Forest virus infection. J. Neurol. Sci. 96:1990;293-302.
39. - T lymphocytes. J. Immunol. 127:1981;1420-1423.
40. Piddlesden S.J., Lassmann H., Zimprich F., Morgan B.P., Linington C. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am. J. Pathol. 143:1993;555-564.
41. Prineas J.W., Connell F. Remyelination in multiple sclerosis. Ann. Neurol. 5:1979;22-31.
42. Prineas J.W., Kwon E., Cho S., Sharer R., Barnett H., Oleszak L., Hoffman B., Morgan B.P. Immunopathology of secondary-progressive multiple sclerosis. Ann. Neurol. 50:2001;646-657.
43. Raine C.S., Mokhtarian F., McFarlin D.E. Adoptively transferred chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Neuropathologic analysis. Lab. Invest. 51:1984;534-546.
44. Raine C.S., Cannella B., Hauser S., Genain C.P. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann. Neurol. 46:1999;144-160.
45. Schlissel M.S., Corcoran L.M., Baltimore D. Virus-transformed pre-B cells show ordered activation but not inactivation of immunoglobulin gene rearrangement and transcription. J. Exp. Med. 173:1991;711-720.
46. Simas J.P., Dyson H., Fazakerley J.K. The neurovirulent GDVII strain of Theiler's virus can replicate in glial cells. J. Virol. 69:1995;5599-5606.
47. Smith-Norowitz T.A., Sobel R.A., Mokhtarian F. B cells and antibodies in the pathogenesis of myelin injury in Semliki Forest virus encephalomyelitis. Cell. Immunol. 200:2000;27-35.
48. Stohlman S.A., Hinton D.R. Viral-induced demyelination. Brain Pathol. 11:2001;92-106.
49. Subak-Sharpe I., Dyson H., Fazakerley J. In vivo depletion of CD8+ T cells prevents lesions of demyelination in Semliki Forest virus infection. J. Virol. 67:1993;7629-7633.
50. Suckling A.J.S., Pathak S., Jagelman S., Webb H.E. Virus-associated demyelination: a model using avirulent Semliki Forest virus infection of mice. J. Neurol. Sci. 29:1978;109.
51. Suzuki K., Andrews J., Waltz J.M., Terry R.D. Ultrastructural studies of multiple sclerosis. Lab. Invest. 20:1969;444-454.
52. Trottier M., Kallio P., Wang W., Lipton H.L. High numbers of viral RNA copies in the central nervous system of mice during the persistent infection with Theiler's virus. J. Virol. 75:2001;7420-7428.
53. Tschen S.I., Bergmann C.C., Ramakrishna C., Morales S., Atkinson R., Stohlman S.A. Recruitment kinetics and composition of antibody-secreting cells within the nervous system following viral encephalomyelitis. J. Immunol. 168:2002;2922-2929.
54. Van der Goes A., Kortekaas M., Hoekstra K., Dijkstra C.D., Amor S. The role of anti-myelin (auto)-antibodies in the phagocytosis of myelin by macrophages. J. Neuroimmunol. 101:1999;61-67.
55. Warrington A., Asakura K., Bieber A., Ciric B., Keulen V., Kaveri S., Kyle R., Pease L., Rodriguez M. Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 97:2000;6820-6825.
56. Willenborg D.O., Prowse S.J. Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis. J. Neuroimmunol. 5:1983;99-109.
57. Wucherpfennig K.W., Strominger J.L. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 8:1995;695-705.
58. Yu M., Johnson J.M., Tuohy V.K. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183:1996;1777-1788.
59. Zamvil S.S., Mitchell D.J., Moore C.A., Kitamura K., Steinman L., Rothbard J.B. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature. 324:1986;258-260.
60. Zhoa Z.S., Granucci F., Yeh L., Schaffer P.A., Cantor H. Molecular mimicry by Herpes Simplex Virus-Type 1: autoimmune disease after viral infection. Science. 279:1998;1344-1347.